Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Adding Combined Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? A Double Blind Placebo Controlled Study.

NCT02562053 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT02562053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02562053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Adding Combined Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? A Double Blind Placebo Controlled Study.
Lead sponsor
Cairo University
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2015
Completion date
September 30, 2017
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

premenstrual syndrome